Zhende Medical Hits Day Low of CNY 88.20 Amid Price Pressure

Zhende Medical Co., a prominent player in the Pharmaceuticals & Biotechnology sector, experienced a notable decline today, with its stock price dropping by 4.03% on March 23, 2026. The stock reached an intraday low of CNY 88.20, reflecting a challenging trading environment. In terms of performance metrics, Zhende Medical's one-day performance contrasts with the China Shanghai Composite, which fell by 3.63%. Over the past week, the company has seen a decrease of 3.52%, while its one-month performance remains positive at 3.33%. However, the year-to-date performance stands at 26.24%, significantly outperforming the broader market index, which is down by 3.92%. Despite a remarkable one-year return of 313.18%, the company faces underlying financial pressures, including a net profit decline of 35.01% and a high debt-equity ratio of 5.96%. The return on equity is reported at 6.50%, indicating a fair valuation with a price-to-book ratio of 2.03. As Zhende Medical navigates these financial dynamics, its stock performance continues to attract attention in the market.